Riskpilot← Back to searchSign inGet full accessWall Medical AB
ABActiveOrg 5592462674Gripsholmsvägen 30Beauty care and other beauty treatment activities · NACE 9622Est. 20200 employees
Revenue 2025
SEK 243K
-8% vs 2024
EBITDA margin
-3.6%
-205% vs 2024
Equity ratio
3.7%
Financial strength
Net profit 2025
SEK -45K
+22% vs 2024
| Revenue | SEK 243K | -8% |
| EBITDA | SEK -9K | -205% |
| Net profit | SEK -45K | +22% |
| Total assets | SEK 669K | +436% |
| Equity | SEK 24K | +154% |
| Employees | 0 | — |
Legal name
Wall Medical AB
Org number
5592462674
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
4 mars 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska erbjuda medicinsk läkarkonsultaton samt utbildningar och föreläsningar inom det medicinska området. Bolaget skall även äga och förvalta fast och lös egendom. Aktiebolaget ska även erbjuda design- och inredningskonsultation inom miljöer där vård bedrivs samt på den icke kommersiella marknaden.
Address
Gripsholmsvägen 30
Email
info@wallmedical.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 98 | 296 | 264 | 243 |
| Staff expenses | — | −5 | −12 | −4 | −12 |
| EBITDA | −37 | −100 | 84 | 8 | −9 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −37 | −100 | 84 | 8 | −9 |
| Net financials | — | — | −0 | −66 | −37 |
| Profit before tax | −37 | −100 | 84 | −58 | −45 |
| Tax | −0 | — | −2 | — | — |
| Net profit | −37 | −100 | 82 | −58 | −45 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 30 | 49 | 162 | 125 | 669 |
| Equity | 30 | −69 | 13 | −45 | 24 |
| Long-term debt | 0 | — | — | — | 585 |
| Short-term debt | 0 | 119 | 149 | 170 | 59 |
| Total debt | — | 119 | 149 | 170 | 644 |
EBITDA margin
-3.6%
This company
15.8%
Market median
-123% vs market
20212025
Equity ratio
3.7%
This company
38.2%
Market median
-90% vs market
20212025
Return on equity
-184.8%
This company
18.4%
Market median
-1104% vs market
20212025
Net profit margin
-18.6%
This company
8.1%
Market median
-330% vs market
20212025
Asset turnover
0.36×
This company
1.12×
Market median
-68% vs market
20212025
Debt / equity
26.31×
This company
0.62×
Market median
-4144% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-02-28
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-03-01 – 2024-02-28
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-03-01 – 2023-02-28
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-03-01 – 2022-02-28
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-03-01 – 2021-02-28
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Wall Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hesam Akbari | Deputy Board Member | 0 companies |
| Homayoun Moazzami | Deputy Board Member | 0 companies |
| Sarah Maria Wall | Board of Directors | 0 companies |